Major trial tests powerful drug combo to keep ovarian cancer at bay
Disease control
Recruiting now
This large international study is testing which treatment strategy works better to control advanced ovarian, fallopian tube, or peritoneal cancer after initial chemotherapy. It compares taking the drug niraparib alone versus taking niraparib plus another drug called bevacizumab. …
Phase: PHASE3 • Sponsor: AGO Study Group • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC